Brazilian City of Porto Velho Implements Regulations on E-Cigarette Usage

Regulations by 2FIRSTS.ai
Nov.29.2023
Brazilian City of Porto Velho Implements Regulations on E-Cigarette Usage
Brazil's Porto Velho city has implemented regulations and launched a week-long campaign to control the use of e-cigarettes.

According to local media reports, the city of Porto Velho in Brazil has now implemented regulations to control the use of e-cigarettes, along with a week-long campaign to raise awareness about the risks associated with their use. The legislation was proposed by Congressman Enfermeiro Roneudo and was approved by the Porto Velho City Council in August of this year. It has since been signed into law by Mayor Hildon Chaves.

 

Roni Eido emphasized the crucial importance of informing users about the dangers of using e-cigarettes. When explaining the purpose of legislation, he stated that the use of nicotine-containing e-cigarettes increases a range of serious health risks, including the inhalation of toxins resulting in seizures, addiction, and respiratory damage. He further expressed that the goal of the law is to educate citizens about the hazards of e-cigarettes, as they are detrimental to health and have the potential to lead to addiction.

 

The e-cigarette, also known as an electronic vaporizer, is a device that uses electricity to vaporize e-liquid containing nicotine and other additives. Despite the ban on sales imposed by the Brazilian National Health Surveillance Agency (ANVISA), this device remains difficult to prohibit in Brazil.

 

E-cigarettes come in various shapes and sizes, some resembling traditional cigarettes while others resemble pens or USB devices. However, the working mechanism of all e-cigarettes is similar: a battery powers a resistor, which heats the e-cigarette liquid and generates vapor that is inhaled by the user.

 

While e-cigarettes were initially marketed as a safer alternative to traditional cigarettes, scientific evidence suggests that the risks associated with their use are very serious. Despite the fact that the vapor produced by e-cigarettes appears to be less harmful than the smoke from traditional tobacco, e-cigarette e-liquid still contains a significant amount of toxic and carcinogenic substances. Not only does it contain nicotine, but it also contains propylene glycol and glycerin, all of which can potentially be inhaled into the lungs and damage the respiratory system.

 

In addition, e-cigarettes pose other risks. Prolonged use may lead to respiratory diseases, cardiovascular diseases, and mental health issues. Improper handling of e-cigarettes can also be dangerous, such as battery overheating that may result in explosions and burns. E-cigarettes are particularly harmful to teenagers as they are in a developmental stage and more sensitive to the negative effects of smoking. The use of e-cigarettes can lead to nicotine addiction and increase the risk of future smoking-related health problems.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Nepal: 80 cartons of e-cigarettes seized, valued at US$150,000
Nepal: 80 cartons of e-cigarettes seized, valued at US$150,000
In Nepal’s Mustang district, authorities seized 80 cartons of e-cigarettes valued at NPR 22,459,320 (approximately US$150,000) in Lomanthang Rural Municipality-4, Nechung, and detained a 32-year-old man, Pema Lama. The account says the e-cigarettes were allegedly brought illegally from China three to four days earlier and loaded near the Korala Nepal–China border point before being intercepted.
Jan.13 by 2FIRSTS.ai
From Tamarind’s AI Shift to Industry Restructuring, The ‘Amazon Moment’ for Nicotine Is Approaching
From Tamarind’s AI Shift to Industry Restructuring, The ‘Amazon Moment’ for Nicotine Is Approaching
Tamarind Intelligence’s decision to appoint a technology-sector executive as chief executive officer signals more than a leadership reshuffle at a specialist data firm. It reflects a broader structural shift across the global nicotine industry, where companies, regulators and intelligence providers are embedding artificial intelligence into core operations.
Special Report
Feb.18
Kenya’s BAT Kenya resumes Velo nicotine pouches after citing regulatory clarity
Kenya’s BAT Kenya resumes Velo nicotine pouches after citing regulatory clarity
BAT Kenya says it has resumed sales of Velo oral nicotine pouches after receiving regulatory clarity, reinforcing its push into non-combustible products as cigarette consumption falls.The company reported a 10% drop in turnover in 2025, with revenue closing at KSh23.2 billion (about $178.64 million), largely attributed to the growing presence of illegal tobacco products.
Mar.03 by 2FIRSTS.ai
BlackRock Enters Top Shareholder Ranks as KT&G Holding Reaches 5.01%
BlackRock Enters Top Shareholder Ranks as KT&G Holding Reaches 5.01%
BlackRock increased its stake in KT&G to 5.01% after purchasing 68,646 shares, bringing total holdings to 5,914,169 shares and triggering Korea’s large-shareholding disclosure rules. KT&G shares climbed to an all-time intraday high of 153,900(about US$106.19) won and closed at a record 152,900(about US$105.50) won. KT&G is set to report earnings on Feb. 5, with consensus pointing to year-on-year growth in revenue and operating profit.
Jan.30 by 2FIRSTS.ai
KDCA youth panel: health indicators worsen with grade level; liquid e-cigarette use tops cigarettes among 11th-grade students
KDCA youth panel: health indicators worsen with grade level; liquid e-cigarette use tops cigarettes among 11th-grade students
Korea Disease Control and Prevention Agency’s Youth Health Panel Survey (2025) Final Results Report says key adolescent health indicators worsen as students move up grade levels. By 11th grade, lifetime tobacco experience rose to 9.59%. Among 11th-grade girls, current use of liquid e-cigarettes (1.54%) surpassed conventional cigarettes (1.33%) for the first time.
Feb.10 by 2FIRSTS.ai
Qnovia’s Heat-Free Inhalable Nicotine Replacement Therapy Posts Positive First-in-Human Data, Advances FDA and MHRA Filings as Funding Expands
Qnovia’s Heat-Free Inhalable Nicotine Replacement Therapy Posts Positive First-in-Human Data, Advances FDA and MHRA Filings as Funding Expands
U.S.-based medical startup Qnovia Inc. reported positive results from its first-in-human clinical trial of RespiRx, an inhalable nicotine replacement therapy (NRT) device designed to support smoking cessation.
Innovation
Feb.24